Slingshot Therapeutics

ALTx Therapeutics launches into the Slingshot accelerator with £12.55 million of funding

Based on the pioneering work of British scientist Simon Boulton, ALTx leverages fundamental insights in cancer cell immortalisation to develop novel treatments for cancer Spinning out of The Francis Crick Institute, ALTx will be advanced by Slingshot in collaboration with the Crick with funding from Syncona, the Crick and Cancer Research Horizons. 5 February 2026...